All News

A recent study showed that patients with MPNs treated with Jakafi off a clinical trial still benefited from the drug.

The chemotherapy agent capecitabine causes some patients to lose their fingerprints.

After multiple bouts with cancer, Taylor Hendrix was inspired to become an oncology nurse.

This male breast cancer survivor spent a year in residence in a Zen Buddhist Temple. Then he got cancer. Here’s what he learned.

When a cancer diagnosis requires a lifestyle overhaul, it's important to recognize the gifts this forced transition brings.

A recent review showed that music therapy helped ease symptoms in patients who were undergoing treatment for cancer.

A three-drug approach is proving beneficial for the treatment of multiple myeloma.

Several factors cause women a delay in getting surgery to treat endometrial cancer.

On starting a new chapter, but never forgetting.

I’m not sure that’s the right term. Do I have a choice?

According to recent findings from a phase 3 trial, the immunotherapy Tecentriq (atezolizumab) improved survival compared with docetaxel in patients with advanced non–small cell lung cancer (NSCLC) following the failure of platinum-based chemotherapy.

Approximately 46 percent of patients with breast cancer at high risk for recurrence but low genomic risk according to the 70-gene breast cancer recurrence assay (MammaPrint) might not require adjuvant chemotherapy.